Corbus Pharmaceuticals Holdings Inc. Stock Rallies 5.5%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 5.5% to $10.38 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.

The stock's rise snapped a three-day losing streak.

Corbus Pharmaceuticals Holdings Inc. closed 49.5% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. fell 1.9% to $5.28, Fortress Biotech Inc. rose 3.6% to $2.87, and Viking Therapeutics Inc. fell 1.37% to $33.89.

Trading volume totaled 603,376, compared to the 50-day average of 385,956.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 21, 2026 16:33 ET (20:33 GMT)